Nanomedicine: Nanotechnology, Biology and Medic...

PHILADELPHIA, Pennsylvania, February 21 /PRNewswire/ --     Elsevier (LSE: REL ,
NYSE: ENL), the world's leading scientific,
technical and medical publisher has announced that its journal, Nanomedicine:
Nanotechnology, Biology and Medicine has been selected for inclusion in
MEDLINE(R). Maintained by the U.S. National Library of Medicine(R), MEDLINE
(Medical Literature Analysis and Retrieval System Online) is the premier
bibliographic database containing approximately 13 million references to
journal articles in life sciences with a concentration on biomedicine.



    Nanomedicine: NBM Editor-in-Chief, Chiming Wei, MD, PhD,
Department of Surgery, Johns Hopkins University School of Medicine,
commented, "The entire Editorial Board and I are extremely pleased that
Nanomedicine: NBM is being added to the MEDLINE journal collection so soon
after its launch in March 2005 in recognition of its scientific merit and
contribution to the field. Inclusion in this prominent database will help
investigators throughout the world more easily locate articles published in
Nanomedicine: NBM.



    Nanomedicine: Nanotechnology, Biology and Medicine
(www.nanomedjournal.org), the Official Journal of the American Academy of
Nanomedicine (AANM), is an international, peer-reviewed journal published
quarterly. Nanomedicine: NBM publishes basic, clinical and engineering
research in the innovative field of nanomedicine. Article categories include
diagnostic, experimental, clinical, engineering, pharmacological and basic
nanomedicine. Nanomedicine: NBM provides the latest information in this
rapidly developing field, covering both research advancements and clinical
applications. The Journal publishes original clinical and investigative
studies, state-of-the-art papers, reports on new equipment and techniques,
review articles and more.



    Nanomedicine, an offshoot of nanotechnology, refers to highly
specific medical intervention at the molecular scale for curing disease or
repairing damaged tissues, such as bone, muscle or nerve. A nanometer is
one-billionth of a meter, too small to be seen with a conventional lab
microscope. It is at this size scale - about 100 nanometers or less - that
biological molecules and structures inside living cells operate.



    The National Library of Medicine MEDLINE selection process is
managed by an advisory committee, the Literature Selection Technical Review
Committee, composed of authorities knowledgeable in the field of biomedicine,
such as physicians, researchers, educators, editors, health science
librarians and historians, to review and recommend the journal titles NLM
should index. With inclusion in MEDLINE, citations, abstracts and indexing
terms for articles published in Nanomedicine: NBM will be available online in
the U.S. and throughout the world back to Volume 1/Issue 1. MEDLINE is
searchable for free using PubMed at http://pubmed.gov.



    Elsevier, a world-leading medical and scientific publisher,
brings the full support of its global organization to the journal. It is
recognized for its numerous long-standing and successful society-publishing
partnerships, as well as excellence in all aspects of the publishing process.
ScienceDirect (www.sciencedirect.com), Elsevier's world-class electronic
platform with over 16 million users, provides online access to the full text
of Nanomedicine: NBM to institutional subscribers. Members of the affiliated
society and individual subscribers are able to access the journal via
www.nanomedjournal.org.



ABOUT THE AMERICAN ACADEMY OF NANOMEDICINE

    The American Academy of Nanomedicine (www.aananomed.org) is a
forum to exchange ideas, communicate new findings and encourage collaboration
among the diverse disciplines represented in Nanomedicine. Membership in AANM
includes a subscription to Nanomedicine: Nanotechnology, Biology, and
Medicine.



ABOUT ELSEVIER

    Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with the
global science and health communities, Elsevier's 7,000 employees in over 70
offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as ScienceDirect (http://www.sciencedirect.com/), MD Consult (
http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases and online reference works.



    Elsevier (http://www.elsevier.com/) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of
Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).